Skip to main content

Advertisement

Log in

Opioidinduzierter Pruritus

Mechanismen und therapeutische Ansätze

Opioid-induced pruritus

Mechanisms and treatment regimens

  • Schmerztherapie
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Zusammenfassung

In der Erforschung von Interaktionen zwischen Schmerz und Juckreiz sind in den letzten Jahren erhebliche Fortschritte erzielt worden. Über die bekannte Hemmung von Juckreiz durch schmerzhafte Reize (z. B. kratzen) hinaus wurde durch die Entdeckung von juckreizspezifischen neuronalen Verarbeitungsbahnen eine Grundlage zur Erklärung von opioidinduziertem Juckreiz geschaffen. Während traditionell die mastzelldegranulierende Wirkung von Opioiden als wesentlicher Mechanismus angenommen wurde, ist nunmehr klar, dass Opioide auch auf spinaler Ebene Juckreiz auslösen können: Spinale Juckreizneurone werden tonisch von Hinterhornneuronen des Schmerzsystems gehemmt. Wird diese Hemmung durch Opioide geschwächt, werden die so disinhibierten Juckreizneurone aktiv und vermitteln Juckreiz, ohne dass primäre Afferenzen in der Peripherie erregt werden. Die spinale Auslösung von Juckreiz wird insbesondere bei der Aktivierung von µ-Opioidrezeptoren (μ-OR) beobachtet, während κ-OR überraschenderweise den Juckreiz unterdrücken. Die therapeutischen Implikationen dieser Interaktionen werden im vorliegenden Beitrag ausgeführt.

Abstract

Substantial progress has been achieved in recent years in research on the interaction between pain and pruritus. Over and above the known inhibition of pruritus by painful stimuli (e.g. scratching), a foundation for the explanation of opioid-induced pruritus was laid through the discovery of pruritus-specific neuronal processing channels. Although traditionally the degranulating effect of opioids on mast cells was assumed to be the essential mechanism, it is now clear that opioids can also induce itching at the spinal level. Neurons of the dorsal horn of the pain system inhibit spinal itch neurons. If this inhibition is weakened by opioids, the disinhibited itch neurons become active and mediate itching, without stimulation of the primary afferent peripheral nerves. Spinal triggering of itching is observed in particular by activation of µ-opioid receptors (μ-OR), while κ-OR surprisingly suppress itch. The therapeutic implications of this interaction will be described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Twycross R, Greaves MW, Handwerker H et al (2003) Itch: scratching more than the surface. QJM 96:7–26

    Article  PubMed  CAS  Google Scholar 

  2. Ikoma A, Steinhoff M, Stander S et al (2006) The neurobiology of itch. Nat Rev Neurosci 7:535–547

    Article  PubMed  CAS  Google Scholar 

  3. Katcher J, Walsh D (1999) Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride. J Pain Symptom Manage 17:70–72

    Article  PubMed  CAS  Google Scholar 

  4. Schmelz M, Schmidt R, Bickel A et al (1997) Specific C-receptors for itch in human skin. J Neurosci 17:8003–8008

    PubMed  CAS  Google Scholar 

  5. Andrew D, Craig AD (2001) Spinothalamic lamina 1 neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 4:72–77

    Article  PubMed  CAS  Google Scholar 

  6. Stander S, Schmelz M (2006) Chronic itch and pain – similarities and differences. Eur J Pain 10:473–478

    Article  PubMed  Google Scholar 

  7. Koppert W, Blunk JA, Petersen LJ et al (2001) Different patterns of mast cell activation by muscle relaxants in human skin. Anesthesiology 95:659–667

    Article  PubMed  CAS  Google Scholar 

  8. Blunk JA, Schmelz M, Zeck S et al (2004) Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in nivo microdialysis study in human skin. Anesth Analg 98:364–370

    Article  PubMed  CAS  Google Scholar 

  9. Nilsson HJ, Levinsson A, Schouenborg J (1997) Cutaneous field stimulation (CFS): a new powerful method to combat itch. Pain 71:49–55

    Article  PubMed  CAS  Google Scholar 

  10. Nagy I, Santha P, Jancso G, Urban L (2004) The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur J Pharmacol 500:351–369

    Article  PubMed  CAS  Google Scholar 

  11. Leffler A, Fischer MJ, Rehner D et al (2008) The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons. J Clin Invest 118:763–776

    PubMed  Google Scholar 

  12. Vyklicky L, Novakova-Tousova K, Benedikt J et al (2008) Calcium-dependent desensitization of vanilloid receptor TRPV1: a mechanism possibly involved in analgesia induced by topical application of capsaicin. Physiol Res (in press)

  13. Simone DA, Nolano M, Johnson T et al (1998) Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function. J Neurosci 18:8947–8954

    PubMed  CAS  Google Scholar 

  14. Stander S, Moormann C, Schumacher M et al (2004) Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells and epithelial cells of appendage structures. Exp Dermatol 13:129–139

    Article  PubMed  Google Scholar 

  15. Simone DA, Baumann TK, LaMotte RH (1989) Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 38:99–107

    Article  PubMed  CAS  Google Scholar 

  16. Andrew D, Schmelz M, Ballantyne JC (2003) Itch – mechanisms and mediators. In: Dostrovsky JO, Carr DB, Koltzenburg M (eds) Progress in pain research and management. IASP, Seattle, pp 213–226

  17. Ko MC, Song MS, Edwards T et al (2004) The role of central mu opioid receptors in opioid-induced itch in primates. J Pharmacol Exp Ther 310:169–176

    Article  PubMed  CAS  Google Scholar 

  18. Heyer G, Groene D, Martus P (2002) Efficacy of naltrexone on acetylcholine-induced alloknesis in atopic eczema. Exp Dermatol 11:448–455

    Article  PubMed  CAS  Google Scholar 

  19. Bergasa NV (2008) Pruritus in primary biliary cirrhosis: pathogenesis and therapy. Clin Liver Dis 12:385–406

    Article  PubMed  Google Scholar 

  20. Jones EA, Neuberger J, Bergasa NV (2002) Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. QJM 95:547–552

    Article  PubMed  CAS  Google Scholar 

  21. Thornton JR, Losowsky MS (1988) Opioid peptides and primary biliary cirrhosis. BMJ 297:1501–1504

    PubMed  CAS  Google Scholar 

  22. Marzioni M, Svegliati BG, Alpini G, Benedetti A (2007) Endogenous opioid peptides and chronic liver disease: from bedside to bench. J Hepatol 46:583–586

    Article  PubMed  CAS  Google Scholar 

  23. Maxwell LG, Kaufmann SC, Bitzer S et al (2005) The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: a double-blind, prospective, randomized, controlled study. Anesth Analg 100:953–958

    Article  PubMed  CAS  Google Scholar 

  24. Greenwald PW, Provataris J, Coffey J et al (2005) Low-dose naloxone does not improve morphine-induced nausea, vomiting, or pruritus. Am J Emerg Med 23:35–39

    Article  PubMed  Google Scholar 

  25. Kjellberg F, Tramer MR (2001) Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur J Anaesthesiol 18:346–357

    Article  PubMed  CAS  Google Scholar 

  26. Ko MC, Husbands SM (2009) Effects of atypical kappa opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. J Pharmacol Exp Ther 328(1):193–200, DOI 10.1124/jpet.108.143925

    Article  PubMed  CAS  Google Scholar 

  27. Lee H, Naughton NN, Woods JH, Ko MC (2007) Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology 107:478–485

    Article  PubMed  CAS  Google Scholar 

  28. Ko MC, Lee H, Song MS et al (2003) Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. J Pharmacol Exp Ther 305:173–179

    Article  PubMed  CAS  Google Scholar 

  29. Delmez JA (2006) Efficacy and safety of a new kappa-opioid receptor agonist for the treatment of uremic pruritus. Nat Clin Pract Nephrol 2:358–359

    Article  PubMed  Google Scholar 

  30. Yeh YC, Lin TF, Lin FS et al (2008) Combination of opioid agonist and agonist-antagonist: patient-controlled analgesia requirement and adverse events among different-ratio morphine and nalbuphine admixtures for postoperative pain. Br J Anaesth 101:542–548

    Article  PubMed  CAS  Google Scholar 

  31. Dawn AG, Yosipovitch G (2006) Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol 54:527–531

    Article  PubMed  Google Scholar 

  32. Gunter JB, McAuliffe J, Gregg T et al (2000) Continuous epidural butorphanol relieves pruritus associated with epidural morphine infusions in children. Paediatr Anaesth 10:167–172

    Article  PubMed  CAS  Google Scholar 

  33. Sakai T, Fukano T, Sumikawa K (2001) IV butorphanol reduces analgesia but not pruritus or nausea associated with intrathecal morphine. Can J Anaesth 48:831–832

    Article  PubMed  CAS  Google Scholar 

  34. Horta ML, Morejon LC, da Cruz AW et al (2006) Study of the prophylactic effect of droperidol, alizapride, propofol and promethazine on spinal morphine-induced pruritus. Br J Anaesth 96:796–800

    Article  PubMed  CAS  Google Scholar 

  35. Bonnet MP, Marret E, Josserand J, Mercier FJ (2008) Effect of prophylactic 5-HT3 receptor antagonists on pruritus induced by neuraxial opioids: a quantitative systematic review. Br J Anaesth 101:311–319

    Article  PubMed  CAS  Google Scholar 

  36. Schmidt S, Bethge C, Forster MH, Schafer M (2007) Enhanced postoperative sensitivity to painful pressure stimulation after intraoperative high dose remifentanil in patients without significant surgical site pain. Clin J Pain 23:605–611

    Article  PubMed  Google Scholar 

  37. Hansen EG, Duedahl TH, Romsing J et al (2005) Intra-operative remifentanil might influence pain levels in the immediate post-operative period after major abdominal surgery. Acta Anaesthesiol Scand 49:1464–1470

    PubMed  CAS  Google Scholar 

  38. Brull SJ, Atanassoff PG, Silverman DG et al (1999) Attenuation of experimental pruritus and mechanically evoked dysesthesiae in an area of cutaneous allodynia. Somatosens Mot Res 16:299–303

    Article  PubMed  CAS  Google Scholar 

  39. Mitra S (2008) Opioid-induced hyperalgesia: pathophysiology and clinical implications. J Opioid Manag 4:123–130

    PubMed  Google Scholar 

  40. Chu LF, Angst MS, Clark D (2008) Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 24:479–496

    Article  PubMed  Google Scholar 

  41. Ruan X (2007) Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician 10:357–366

    PubMed  Google Scholar 

  42. Labuz D, Berger S, Mousa SA et al (2006) Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. J Neurosci 26:4350–4358

    Article  PubMed  CAS  Google Scholar 

  43. Bigliardi-Qi M, Sumanovski LT, Buchner S et al (2004) Mu-opiate receptor and beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology 209:183–189

    Article  PubMed  CAS  Google Scholar 

  44. Tobin DJ, Kauser S (2005) Beta-endorphin: the forgotten hair follicle melanotropin. J Investig Dermatol Symp Proc 10:212–216

    Article  PubMed  CAS  Google Scholar 

  45. Bigliardi-Qi M, Lipp B, Sumanovski LT et al (2005) Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 210:91–99

    Article  PubMed  CAS  Google Scholar 

  46. Chan LS, Robinson N, Xu L (2001) Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 117:977–983

    Article  PubMed  CAS  Google Scholar 

  47. Tredget EE, Yang L, Delehanty M et al (2006) Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res 26:179–189

    Article  PubMed  CAS  Google Scholar 

  48. Roy S, Wang J, Charboneau R et al (2005) Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase A pathway. J Immunol 175:6361–6367

    PubMed  CAS  Google Scholar 

  49. Birklein F, Claus D, Riedl B et al (1997) Effects of cutaneous histamine application in patients with sympathetic reflex dystrophy. Muscle Nerve 20:1389–1395

    Article  PubMed  CAS  Google Scholar 

  50. Ikoma A, Fartasch M, Heyer G et al (2004) Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch. Neurology 62:212–217

    Article  PubMed  CAS  Google Scholar 

  51. Charuluxananan S, Kyokong O, Somboonviboon W et al (2003) Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesth Analg 96:1789–1793

    Article  PubMed  CAS  Google Scholar 

  52. Kjellberg F, Tramer MR (2001) Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur J Anaesthesiol 18:346–357

    Article  PubMed  CAS  Google Scholar 

Download references

Danksagung

Diese Arbeit wurde von der Deutschen Forschungsgemeinschaft (KFO 107) unterstützt.

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Schmelz MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmelz, M. Opioidinduzierter Pruritus. Anaesthesist 58, 61–65 (2009). https://doi.org/10.1007/s00101-008-1478-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-008-1478-8

Schlüsselwörter

Keywords

Navigation